Skip to main content
SpringerLink
Log in

Therapeutic drug monitoring can improve the ratio of costs to benefits for some drugs

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bochner F, Tonkin A. Med J Aust 158: 422–426, 1993

    PubMed  CAS  Google Scholar 

  2. Drugs Ther Perspect 2: 14–16, 2 Aug 1993

  3. Bertino JS, et al. Clin Pharmacokinet 26: 71–81, 1994

    Article  PubMed  Google Scholar 

  4. Kimelblatt BJ, et al. Am J Hosp Pharm 43: 1205–1209, 1986

    PubMed  CAS  Google Scholar 

  5. Ried LD, et al. Am J Hosp Pharm 46: 945–951, 1989

    PubMed  CAS  Google Scholar 

  6. Destache CJ, et al. Ther Drug Monit 12: 427–433, 1990

    Article  PubMed  CAS  Google Scholar 

  7. Destache CJ, et al. Ther Drug Monit 12: 419–426, 1990

    Article  PubMed  CAS  Google Scholar 

  8. Ried LD, et al. Ther Drug Monit 12: 72–78, 1990

    Article  PubMed  CAS  Google Scholar 

  9. Schloemer JH, Zagozen JJ. Am J Hosp Form 41: 2347–2351, 1984

    CAS  Google Scholar 

  10. Hill RA, Frith RW. New Ethicals 30: 43–50, Apr 1993

    Google Scholar 

  11. Grünenberg RN. Hosp Form 28: 55–58, 1993

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Therapeutic drug monitoring can improve the ratio of costs to benefits for some drugs. Drugs Ther. Perspect 4, 13–16 (1994). https://doi.org/10.2165/00042310-199404020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199404020-00006

Keywords

Search

Navigation